... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > steroid > (NZ)-N-[(9S,13S,14S,16E)-16-hydroxyimino-13-methyl-3-prop-2-enoxy-6,9,11,12,14,15-hexahydrocyclopenta[a]phenanthren-17-ylidene]hydroxylamine

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic molecule > organic cyclic compound > organic polycyclic compound > steroid > (NZ)-N-[(9S,13S,14S,16E)-16-hydroxyimino-13-methyl-3-prop-2-enoxy-6,9,11,12,14,15-hexahydrocyclopenta[a]phenanthren-17-ylidene]hydroxylamine

... > chemical entity > molecular entity > polyatomic entity > molecule > organic molecule > organic cyclic compound > organic polycyclic compound > steroid > (NZ)-N-[(9S,13S,14S,16E)-16-hydroxyimino-13-methyl-3-prop-2-enoxy-6,9,11,12,14,15-hexahydrocyclopenta[a]phenanthren-17-ylidene]hydroxylamine

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > organic cyclic compound > organic polycyclic compound > steroid > (NZ)-N-[(9S,13S,14S,16E)-16-hydroxyimino-13-methyl-3-prop-2-enoxy-6,9,11,12,14,15-hexahydrocyclopenta[a]phenanthren-17-ylidene]hydroxylamine

... > chemical entity > molecular entity > polyatomic entity > molecule > cyclic compound > polycyclic compound > organic polycyclic compound > steroid > (NZ)-N-[(9S,13S,14S,16E)-16-hydroxyimino-13-methyl-3-prop-2-enoxy-6,9,11,12,14,15-hexahydrocyclopenta[a]phenanthren-17-ylidene]hydroxylamine